Contact us

Let’s talk about your next project

Biopharma Partnerships








Myriad needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time by using the unsubscribe link or instructions in any email communications we send. For further information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.

Hidden Fields









Myriad Biopharma

Empowering patients, researchers, and physicians to select the best therapies for precision disease treatment

Myriad Biopharma

Empowering patients, researchers, and physicians to select the best therapies for precision disease treatment

Biopharma services

0

Trusted companion diagnostic development

Pharmaceutical and biotech partners can leverage our CDx development capabilities for custom end-to-end projects.

0

Customized clinical trial testing

Our dedicated team has supported hundreds of clinical trials and can lend our expertise in genetics and CDx to your patient samples.

The Myriad Genetics difference

Genetics pioneers

For more than 30 years, we’ve driven industry-leading advances in genetics. Myriad completed the initial cloning of BRCA1 and BRCA2 in the 1990s, and today we’re advancing our understanding of homologous recombination deficiency and the genetics of cancer risk — but we’re just getting started.

Deep regulatory expertise

Our extensive regulatory work throughout the United States, Europe and Japan uniquely positions Myriad as a valuable, experienced partner in navigating regulatory agencies worldwide.

Global reach

With labs in the U.S. and a partnership in China, Myriad can receive and test samples from all over the world, benefitting patients, researchers, physicians, and pharmaceutical companies around the globe.